Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 3406 AL 3420

Prediction of Parkinson's disease subsequent to severe depression: a ten-year follow-up study

Walter U, Heilmann R, Kaulitz L, Just T, Krause BJ, Benecke R, Höppner J.

J Neural Transm (Vienna). 2015 Jun;122(6):789-97. doi: 10.1007/s00702-014-1313-0. Epub 2014 Sep 14.

The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?

Doty KR, Guillot-Sestier MV, Town T.

Brain Res. 2015 Aug 18;1617:155-73. doi: 10.1016/j.brainres.2014.09.008. Epub 2014 Sep 8.

Role of transcriptional control in multiple system atrophy

Chen J, Mills JD, Halliday GM, Janitz M.

Neurobiol Aging. 2015 Jan;36(1):394-400. doi: 10.1016/j.neurobiolaging.2014.08.015. Epub 2014 Aug 19.

NGLY1 mutation causes neuromotor impairment, intellectual disability, and neuropathy

Caglayan AO, Comu S, Baranoski JF, Parman Y, Kaymakçalan H, Akgumus GT, Caglar C, Dolen D, Erson-Omay EZ, Harmanci AS, Mishra-Gorur K, Freeze HH, Yasuno K, Bilguvar K, Gunel M.

Eur J Med Genet. 2015 Jan;58(1):39-43. doi: 10.1016/j.ejmg.2014.08.008. Epub 2014 Sep 9.

Dance for people with Parkinson disease: what is the evidence telling us?

Shanahan J, Morris ME, Bhriain ON, Saunders J, Clifford AM.

Arch Phys Med Rehabil. 2015 Jan;96(1):141-53. doi: 10.1016/j.apmr.2014.08.017. Epub 2014 Sep 16.

Cholinesterase inhibitors for Parkinson's disease: a systematic review and meta-analysis

Pagano G, Rengo G, Pasqualetti G, Femminella GD, Monzani F, Ferrara N, Tagliati M.

J Neurol Neurosurg Psychiatry. 2015 Jul;86(7):767-73. doi: 10.1136/jnnp-2014-308764. Epub 2014 Sep 15.

Pharmacogenetics of drug response in Parkinson's disease

Džoljić E, Novaković I, Krajinovic M, Grbatinić I, Kostić V.

Int J Neurosci. 2015;125(9):635-44. doi: 10.3109/00207454.2014.963851. Epub 2014 Oct 15.

Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype

Swanson CR, Li K, Unger TL, Gallagher MD, Van Deerlin VM, Agarwal P, Leverenz J, Roberts J, Samii A, Gross RG, Hurtig H, Rick J, Weintraub D, Trojanowski JQ, Zabetian C, Chen-Plotkin AS.

Mov Disord. 2015 May;30(6):805-12. doi: 10.1002/mds.26022. Epub 2014 Sep 16.

Thiazolidinediones under preclinical and early clinical development for the treatment of Parkinson's disease

Carta AR, Simuni T.

Expert Opin Investig Drugs. 2015 Feb;24(2):219-27. doi: 10.1517/13543784.2015.963195. Epub 2014 Sep 17.

Effectiveness of risk minimization measures for cabergoline-induced cardiac valve fibrosis in clinical practice in Italy

Italiano D, Bianchini E, Ilardi M, Cilia R, Pezzoli G, Zanettini R, Vacca L, Stocchi F, Bramanti P, Ciurleo R, Di Lorenzo G, Polimeni G, de Luise C, Ross D, Rijnbeek P, Sturkenboom M, Trifirò G.

J Neural Transm (Vienna). 2015 Jun;122(6):799-808. doi: 10.1007/s00702-014-1314-z. Epub 2014 Sep 18.

Clinical features of drug-induced parkinsonism based on [18F] FP-CIT positron emission tomography

Shin HW, Kim JS, Oh M, You S, Kim YJ, Kim J, Kim MJ, Chung SJ.

Neurol Sci. 2015 Feb;36(2):269-74. doi: 10.1007/s10072-014-1945-8. Epub 2014 Sep 18.

Sporadic inclusion-body myositis: A degenerative muscle disease associated with aging, impaired muscle protein homeostasis and abnormal mitophagy

Askanas V, Engel WK, Nogalska A.

Biochim Biophys Acta. 2015 Apr;1852(4):633-43. doi: 10.1016/j.bbadis.2014.09.005. Epub 2014 Sep 18.

Evidence that formulations of the selective MAO-B inhibitor, selegiline, which bypass first-pass metabolism, also inhibit MAO-A in the human brain

Fowler JS, Logan J, Volkow ND, Shumay E, McCall-Perez F, Jayne M, Wang GJ, Alexoff DL, Apelskog-Torres K, Hubbard B, Carter P, King P, Fahn S, Gilmor M, Telang F, Shea C, Xu Y, Muench L.

Neuropsychopharmacology. 2015 Feb;40(3):650-7. doi: 10.1038/npp.2014.214. Epub 2014 Sep 24.

A narrative review of turning deficits in people with Parkinson's disease

Hulbert S, Ashburn A, Robert L, Verheyden G.

Disabil Rehabil. 2015;37(15):1382-9. doi: 10.3109/09638288.2014.961661. Epub 2014 Sep 25.

Manganese Encephalopathy among Ephedron Abusers

Janocha-Litwin J, Marianska K, Serafinska S, Simon K.

J Neuroimaging. 2015 Sep-Oct;25(5):832-5. doi: 10.1111/jon.12173. Epub 2014 Sep 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias